[Clinical use of betamethasone 17-valerate]. 1966

T Kamimura, and N Sasaki

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001623 Betamethasone A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724) Betadexamethasone,Flubenisolone,Celeston,Celestona,Celestone,Cellestoderm
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D014631 Valerates Derivatives of valeric acid, including its salts and esters. Pentanoate,Pentanoates,Valerate

Related Publications

T Kamimura, and N Sasaki
November 1964, Alergia,
T Kamimura, and N Sasaki
November 1966, Semaine therapeutique,
T Kamimura, and N Sasaki
January 1967, Archives belges de dermatologie et de syphiligraphie,
T Kamimura, and N Sasaki
July 1965, La Riforma medica,
T Kamimura, and N Sasaki
October 1964, Medicina,
T Kamimura, and N Sasaki
October 1993, Journal of pharmaceutical sciences,
T Kamimura, and N Sasaki
July 1968, IMJ. Illinois medical journal,
T Kamimura, and N Sasaki
May 1965, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
T Kamimura, and N Sasaki
May 1964, Lancet (London, England),
Copied contents to your clipboard!